Increasing generic drug use, legalizing drug reimportation, establishing electronic health records, and using comparative effectiveness research to a greater extent are possible changes that might take place under the new administration.
You are here
P&T® Journal contents for June 2009
Issues of Interest to P&T Committees
Safety and Efficacy of Red Yeast Rice (Monascus purpureus) as an Alternative Therapy for Hyperlipidemia
Red yeast rice is a dietary supplement with the same chemical structure as lovastatin (Mevacor), but it is not regulated by the FDA. Although patients have used it to reduce cholesterol levels, some serious problems (muscular atrophy, rhabdomyolysis) can result. Inconsistent quality and toxigenic ingredients can cause additional complications.
Some of the topics covered at the ASH sessions were fixed-dose combinations (Lotrel, Lotensin, Benicar HCT, and Azor) as well as an endothelin receptor agonist (darusentan). Therapies presented at the AUA meeting included dutasteride (Avodart) for reducing the risk of prostate cancer; a topical gel of oxybutynin chloride (Gelnique) for treating patients with overactive bladder; and silodosin (Rapaflo) for decreasing symptoms of benign prostatic hyperplasia.
Golimumab (Simponi) for the treatment of arthritis, Benzyl Alcohol Lotion 5% for patients with head lice, and artemether/lumefantine (Coartem/Riamet) tablets for uncomplicated malaria are discussed.